Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 06, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000052.pdf 0001968202-24-000052.xls
Feb 06, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000054.pdf 0001968202-24-000054.xls
Feb 05, 2024	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001804220-24-000009.pdf 0001804220-24-000009.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000048.pdf 0001968202-24-000048.xls
Feb 05, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001972362-24-000074.pdf 0001972362-24-000074.xls
Feb 02, 2024	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-24-000006.pdf 0001804220-24-000006.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 02, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000045.pdf 0001968202-24-000045.xls
Feb 02, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000046.pdf 0001968202-24-000046.xls
Feb 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-000554.pdf 0001950047-24-000554.xls
Feb 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001968582-24-000073.pdf 0001968582-24-000073.xls

Data provided by Kaleidoscope.

Investors & Media